Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil versus placebo in men with LUTS secondary to benign prostatic hyperplasia undergoing prostatectomy
2014-004422-17Phase 4Active
- Sponsor
- Università degli Studi di Firenze
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, double-blind trial of tadalafil in benign prostatic hyperplasia (BPH) and Micturition disorder (2 arms), sponsored by Università degli Studi di Firenze. Primary endpoint: Improvement of LUTS/BPH symptoms. Started Jan 2015; status: active.
02
Drugs
tadalafil
03
Conditions
benign prostatic hyperplasia (BPH)Micturition disorder
Beyond the preview
Go deeper on 2014-004422-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004422-17.